Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
about
Diverse roles of macrophages in atherosclerosis: from inflammatory biology to biomarker discoveryDifferential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cellsThe molecular mechanisms of the thrombotic complications of atherosclerosisRole of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosisElevated levels of matrix metalloprotein-3 in patients with coronary aneurysm: A case control studyPlasma matrix metalloproteinases, low density lipoprotein oxidisability and soluble adhesion molecules after a glucose load in Type 2 diabetesSuppression of MMP-9 by doxycycline in brain arteriovenous malformationsMonocyte matrix metalloproteinase production in Type 2 diabetes and controls--a cross sectional studyBHUx: A Patent Polyherbal Formulation to Prevent AtherosclerosisInvolvement of CD147 in overexpression of MMP-2 and MMP-9 and enhancement of invasive potential of PMA-differentiated THP-1.Matrix metalloproteinases in exercise and obesityMatrix Metalloproteinases in Non-Neoplastic Disorders.The Role of Different Monocyte Subsets in the Pathogenesis of Atherosclerosis and Acute Coronary SyndromesGene silencing of TACE enhances plaque stability and improves vascular remodeling in a rabbit model of atherosclerosis.Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis DevelopmentIntravascular optical imaging of high-risk plaques in vivo by targeting macrophage mannose receptors.Biomechanical factors and macrophages in plaque stabilityMacrophage metalloelastase, MMP-12, cleaves human apolipoprotein(a) in the linker region between kringles IV-4 and IV-5. Potential relevance to lipoprotein(a) biologyStructural analysis of the alpha(2) integrin I domain/procollagenase-1 (matrix metalloproteinase-1) interactionProgression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expressionVasomotor effects of L- and D-arginine in stenotic atheromatous coronary plaqueMacrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromesTissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosisCa2+ channel blockers modulate metabolism of collagens within the extracellular matrixEnvironmental arsenic exposure and serum matrix metalloproteinase-9Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaBEffect of a dipeptidyl peptidase-IV inhibitor, des-fluoro-sitagliptin, on neointimal formation after balloon injury in ratsAcrolein activates matrix metalloproteinases by increasing reactive oxygen species in macrophagesMacrophages in the pathogenesis of atherosclerosisPredictors of Plaque Progression in Hypertensive Angina Patients with Achieved Low-Density Lipoprotein Cholesterol Less Than 70 mg/dL after Rosuvastatin Treatment.Imaging atherosclerosis and vulnerable plaque.PDGF-DD, a novel mediator of smooth muscle cell phenotypic modulation, is upregulated in endothelial cells exposed to atherosclerosis-prone flow patternsMolecular mechanisms of collagen isotype-specific modulation of smooth muscle cell phenotypeDegraded collagen fragments promote rapid disassembly of smooth muscle focal adhesions that correlates with cleavage of pp125(FAK), paxillin, and talinMatrix metalloproteinase 2 and 9 dysfunction underlie vascular stiffness in circadian clock mutant mice.MRI in the early identification and classification of high-risk atherosclerotic carotid plaques.Molecular imaging in atherosclerosis.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) miceNon-destructive label-free monitoring of collagen gel remodeling using optical coherence tomography.
P2860
Q21285000-94359922-2100-4816-BC41-1796B6873673Q24563090-488FF22D-FA08-42B1-9424-FDAF1D31316FQ24656816-E238012A-48CD-48FA-9883-2E956A63C27EQ24672221-0F9A182B-501B-4B92-8146-EA56E0314373Q24792943-71A25E5A-E6B1-4954-B86B-01A1453F3D53Q24798147-D87997B8-F4C8-4C60-9886-9F4FA7394ABDQ24799016-F074F2D8-0634-4EC5-9401-F9FC7431F22AQ24806823-C0E0C010-9E31-4C5E-9844-7E748A932816Q24810118-64E3F144-0C4E-432A-9AC3-941AC5D8EC45Q24810789-BEC658FF-E31D-4FDA-9AC9-423FCE441B3EQ26741022-3A1B2949-E25A-45EB-8244-18AAC4C8FD40Q26741827-54EB7A85-7051-4376-83D0-49A0E274D457Q26852646-476E880D-445C-451D-B12F-D9B095824F08Q27303950-3C350D75-76A3-4CA4-870B-7A4113BA2DCDQ27320886-A395B67F-E1C5-4AEF-B4E8-C6E1E48A1DFAQ27334277-3D02B0A1-6969-40E4-8374-33AF6FAAFF81Q27693877-D516C931-8DEC-4B6A-A24A-B5B7F9444D4BQ28140467-2882019A-17C5-4C89-A6D1-EC577A13B8C6Q28189730-197987C6-5E73-4F7F-9A8F-242FB01CB15BQ28281614-94618B51-8880-47BD-A908-9CE537DC53E8Q28346458-BA7392A8-73E3-449A-8D26-24C6DE302CBBQ28359694-08FCD3F5-A1E1-4116-B086-EBF37D644B01Q28364526-128E5629-6AB0-488E-9D0D-1E4AC0DAA4CFQ28378851-B5F11D83-7ED1-4FD2-9BDF-B1544A1AA75BQ28386467-02688822-B245-4E99-9C8D-6AB1BD9AB01CQ28577934-921506E9-F195-46A9-A927-CCAFC07EC935Q28730724-A4456898-0819-41F2-8E2E-DD7B2B06DFF1Q28754552-ABBD1F50-D95C-4AB2-9CA2-8A76278DE244Q29617765-A7E56584-A398-422E-9CDD-F8411CA030FAQ30394491-20B55C5F-D324-4AE0-9EA8-BC0F002C847CQ30435383-2C9D7992-228F-4412-8DA8-ED656EC26D71Q30437153-63945299-F613-41E9-8A45-E76871182CDBQ30439442-31606594-1899-4F16-BFD2-422229ACE80DQ30442047-2C01CC9E-846F-4C44-B950-3CABBDA75D9DQ30472463-6C8A3A5A-10BD-4AA4-878E-4B1DF7579525Q30478391-44A3B3AB-F800-4219-A2AC-C21E664C0B80Q30478541-018A80CC-F090-4125-B33E-D16FDBE5E57BQ30484224-3054B9BF-BD45-4D7D-9917-3D87EB982073Q30485602-62A5741F-D039-4944-BA73-E98C6FF43A0AQ30496623-236097B4-7104-4D16-9DD5-D4CE0782F267
P2860
Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.
description
1994 nî lūn-bûn
@nan
1994 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Increased expression of matrix ...... human atherosclerotic plaques.
@ast
Increased expression of matrix ...... human atherosclerotic plaques.
@en
Increased expression of matrix ...... human atherosclerotic plaques.
@nl
type
label
Increased expression of matrix ...... human atherosclerotic plaques.
@ast
Increased expression of matrix ...... human atherosclerotic plaques.
@en
Increased expression of matrix ...... human atherosclerotic plaques.
@nl
prefLabel
Increased expression of matrix ...... human atherosclerotic plaques.
@ast
Increased expression of matrix ...... human atherosclerotic plaques.
@en
Increased expression of matrix ...... human atherosclerotic plaques.
@nl
P2093
P2860
P356
P1476
Increased expression of matrix ...... human atherosclerotic plaques.
@en
P2093
P2860
P304
P356
10.1172/JCI117619
P407
P577
1994-12-01T00:00:00Z